REFERENCES
1. Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric
Oncology . 5th ed. Lippincott Williams & Wilkins; 2006.
2. Arora R, Arora B. Acute leukemia in children: A review of the current
Indian data. South Asian J Cancer . 2016;5(3):155.
doi:10.4103/2278-330X.187591
3. Haddy TB, Mosher RB, Reaman GH. Late effects in long-term survivors
after treatment for childhood acute leukemia. Clin Pediatr
(Phila) . 2009;48(6):601-608. doi:10.1177/0009922809332680
4. Krull KR, Brinkman TM, Li C, et al. Neurocognitive outcomes decades
after treatment for childhood acute lymphoblastic leukemia: a report
from the St Jude lifetime cohort study. J Clin Oncol Off J Am Soc
Clin Oncol . 2013;31(35):4407-4415. doi:10.1200/JCO.2012.48.2315
5. Aziz NM. Cancer survivorship research: state of knowledge, challenges
and opportunities. Acta Oncol Stockh Swed . 2007;46(4):417-432.
doi:10.1080/02841860701367878
6. Denlinger CS, Carlson RW, Are M, et al. Survivorship: introduction
and definition. Clinical practice guidelines in oncology. J Natl
Compr Cancer Netw JNCCN . 2014;12(1):34-45. doi:10.6004/jnccn.2014.0005
7. Ganguli M, Blacker D, Blazer DG, et al. Classification of
neurocognitive disorders in DSM-5: a work in progress. Am J
Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry .
2011;19(3):205-210. doi:10.1097/jgp.0b013e3182051ab4
8. Sharma R. Revised Kuppuswamy’s Socioeconomic Status Scale: Explained
and Updated. Indian Pediatr . 2017;54(10):867-870.
9. Wechsler D. WISC-IV India. Wechsler intelligence scale for children -
fourth (India edition) New Delhi: Pearson; 2016.
https://pearsonclinical.in/solutions/wisc-iv-india-complete-kit/
10. Mulrooney DA, Hyun G, Ness KK, et al. The changing burden of
long-term health outcomes in survivors of childhood acute lymphoblastic
leukaemia: a retrospective analysis of the St Jude Lifetime Cohort
Study. Lancet Haematol . 2019;6(6):e306-e316.
doi:10.1016/S2352-3026(19)30050-X
11. Kim SJ, Park MH, Lee JW, et al. Neurocognitive Outcome in Survivors
of Childhood Acute Lymphoblastic Leukemia: Experience at a Tertiary Care
Hospital in Korea. J Korean Med Sci . 2015;30(4):463.
doi:10.3346/jkms.2015.30.4.463
12. Kanellopoulos A, Andersson S, Zeller B, et al. Neurocognitive
Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic
Leukemia After Treatment with Chemotherapy Only: Very Long-Term
Cognitive Outcome After Childhood ALL. Pediatr Blood Cancer .
2016;63(1):133-138. doi:10.1002/pbc.25690
13. Peng L, Yam PP-Y, Yang LS, Sato S, Li CK, Cheung YT. Neurocognitive
impairment in Asian childhood cancer survivors: a systematic review.Cancer Metastasis Rev . 2020;39(1):27-41.
doi:10.1007/s10555-020-09857-y
14. Kurkure P, Achrekar S, Dalvi N, Goswami S. Childhood cancer
survivors–living beyond cure. Indian J Pediatr .
2003;70(10):825-828. doi:10.1007/BF02723807
15. Fletcher JM, Copeland DR. Neurobehavioral effects of central nervous
system prophylactic treatment of cancer in children. J Clin Exp
Neuropsychol . 1988;10(4):495-537. doi:10.1080/01688638808408255
16. Edelstein K, DʼAgostino N, Bernstein LJ, et al. Long-term
Neurocognitive Outcomes in Young Adult Survivors of Childhood Acute
Lymphoblastic Leukemia: J Pediatr Hematol Oncol .
2011;33(6):450-458. doi:10.1097/MPH.0b013e31820d86f2
17. Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of
radiotherapy-associated cognitive disability in patients with brain
tumours. Nat Rev Neurol . 2017;13(1):52-64.
doi:10.1038/nrneurol.2016.185
18. Pui C-H, Campana D, Pei D, et al. Treating Childhood Acute
Lymphoblastic Leukemia without Cranial Irradiation. N Engl J Med .
2009;360(26):2730-2741. doi:10.1056/NEJMoa0900386
19. Cheung YT, Krull KR. Neurocognitive outcomes in long-term survivors
of childhood acute lymphoblastic leukemia treated on contemporary
treatment protocols: A systematic review. Neurosci Biobehav Rev .
2015;53:108-120. doi:10.1016/j.neubiorev.2015.03.016
20. Armstrong FD. Acute leukodystrophy: elevated risk for neurocognitive
impairment and imaging abnormalities. Lancet Haematol .
2016;3(10):e447-e448. doi:10.1016/S2352-3026(16)30129-6
21. Krull KR, Cheung YT, Liu W, et al. Chemotherapy Pharmacodynamics and
Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of
Childhood Acute Lymphoblastic Leukemia. J Clin Oncol .
2016;34(22):2644-2653. doi:10.1200/JCO.2015.65.4574
22. Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive
Outcomes Following Contemporary Treatment Without Cranial Irradiation
for Childhood Acute Lymphoblastic Leukemia. JNCI J Natl Cancer
Inst . 2012;104(18):1386-1395. doi:10.1093/jnci/djs344
23. van der Plas E, Nieman BJ, Butcher DT, et al. Neurocognitive Late
Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia:
Focus on Methotrexate. J Can Acad Child Adolesc Psychiatry J Acad
Can Psychiatr Enfant Adolesc . 2015;24(1):25-32.
24. Krull KR. Dexamethasone and neurocognitive outcomes in survivors of
childhood acute lymphoblastic leukemia. Pediatr Blood Cancer .
2020;67(3). doi:10.1002/pbc.28118
25. Kadan-Lottick NS, Brouwers P, Breiger D, et al. A comparison of
neurocognitive functioning in children previously randomized to
dexamethasone or prednisone in the treatment of childhood acute
lymphoblastic leukemia. Blood . 2009;114(9):1746-1752.
doi:10.1182/blood-2008-12-186502
26. Caron JE, Krull KR, Hockenberry M, Jain N, Kaemingk K, Moore IM.
Oxidative stress and executive function in children receiving
chemotherapy for acute lymphoblastic leukemia. Pediatr Blood
Cancer . 2009;53(4):551-556. doi:10.1002/pbc.22128
27. Protas P, Holownia A, Muszynska-Roslan K, Wielgat P, Krawczuk-Rybak
M, Braszko J. Cerebrospinal Fluid IL-6, TNF-α and MCP-1 in Children with
Acute Lymphoblastic Leukaemia during Chemotherapy.Neuropediatrics . 2011;42(06):254-256. doi:10.1055/s-0031-1295477
28. Cheung YT, Khan RB, Liu W, et al. Association of Cerebrospinal Fluid
Biomarkers of Central Nervous System Injury With Neurocognitive and
Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute
Lymphoblastic Leukemia. JAMA Oncol . 2018;4(7):e180089.
doi:10.1001/jamaoncol.2018.0089
29. Landier W, Skinner R, Wallace WH, et al. Surveillance for Late
Effects in Childhood Cancer Survivors. J Clin Oncol Off J Am Soc
Clin Oncol . 2018;36(21):2216-2222. doi:10.1200/JCO.2017.77.0180
30. Jacola LM, Edelstein K, Liu W, et al. Cognitive, behaviour, and
academic functioning in adolescent and young adult survivors of
childhood acute lymphoblastic leukaemia: a report from the Childhood
Cancer Survivor Study. Lancet Psychiatry . 2016;3(10):965-972.
doi:10.1016/S2215-0366(16)30283-8
31. Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR.
Neurocognitive Outcomes and Interventions in Long-Term Survivors of
Childhood Cancer. J Clin Oncol . 2018;36(21):2181-2189.
doi:10.1200/JCO.2017.76.4696
32. Sleurs C, Madoe A, Lagae L, et al. Genetic Modulation of
Neurocognitive Development in Cancer Patients throughout the Lifespan: a
Systematic Review. Neuropsychol Rev . 2019;29(2):190-219.
doi:10.1007/s11065-019-09399-3
33. Sharkey CM, Clawson AH, Mullins LL, et al. The relationship of child
executive functions to parenting capacities in childhood acute
lymphoblastic leukemia survivors. Pediatr Blood Cancer .
2019;66(8). doi:10.1002/pbc.27761
34. Huang I-C, Brinkman TM, Kenzik K, et al. Association Between the
Prevalence of Symptoms and Health-Related Quality of Life in Adult
Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort
Study. J Clin Oncol . 2013;31(33):4242-4251.
doi:10.1200/JCO.2012.47.8867
35. Thompson SJ, Leigh L, Christensen R, et al. Immediate neurocognitive
effects of methylphenidate on learning-impaired survivors of childhood
cancer. J Clin Oncol Off J Am Soc Clin Oncol .
2001;19(6):1802-1808. doi:10.1200/JCO.2001.19.6.1802